2026 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Insights
Categories
Topics
Categories
Topics
How to Apply a Championship Mentality to Critical Pharmacy Priorities
Negotiating an innovative, best-in-class PBM agreement is akin to knocking it out of the park on draft night and free agency. It is critical,…
Read Post
Five Ways to Use Data for a Stronger Pharmacy Strategy
The engine that drives program optimization is integrated pharmacy and medical analytics. Monitoring data is vital and monitoring it across both medical and pharmacy…
Read Post
Q&A: How to Accelerate Plan Performance Review
Today’s pharmacy benefit landscape can feel like a minefield of complex contracts, performance promises, intricate plan designs, and endless benefit considerations. Employers must trust…
Read Post
2022 Trends in Specialty Drug Benefits Report
Overview Over 30% of plan sponsors are exploring alternate models driven mostly by high-cost specialty medications and the need to reduce inappropriate utilization. Right…
Read Post
Member Experience vs. the Great Resignation: Three Moves to Improve UM
What is the point of negotiating stringent contract terms and conditions if no one ensures the rules are followed? Strategic vendor oversight is the…
Read Post
Rare Disease Day Spotlight: Cystic Fibrosis
What is cystic fibrosis? People tend to consider cystic fibrosis (CF) a pediatric disease; however, it can also affect adults. CF is an…
Read Post
Rewriting the Rule Book: Six Things You Need to Accomplish in The RFP Process
Implementation of best-in-class PBM contracting The negotiation process starts with the bid. A well-managed procurement sets the expectation that the bidding PBMs will…
Read Post
2022 Trends in Benefit Design Report
Pharmaceutical Strategies Group (PSG) is pleased to present the 2022 Trends in Drug Benefit Design Report, which details traditional (non-specialty) drug benefit trends…
Read Post
Plan Sponsor Considerations for OTC-COVID 19 Tests Coverage
On January 10, 2022, guidance was released requiring group health plans and insurers to cover over-the-counter (OTC) COVID-19 diagnostic tests for members without cost…
Read Post
Spotlight on Utilization Management with Sharon Phares, PhD, MPH & Stephen Mackie
Utilization management (UM) programs are a vital tool in the clinical and cost management of drugs. These programs are offered in various forms by…
Read Post
PBM Implementation Results with Mandy Savino
Implementations can drastically impact overall satisfaction with a pharmacy benefit manager (PBM). Here are focused insights on how satisfied plans were with their PBM…
Read Post